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n this issue of PLoS Medicine, 
Renaud Becquet and colleagues 
report their ﬁ  ndings from a new 
study looking at the long-term safety 
of infant feeding interventions aimed 
at reducing mother-to-child HIV 
transmission in Africa [1]. Over two 
years, the researchers studied the safety 
of infant feeding interventions (either 
formula feeding or shortened breast-
feeding) among infants of HIV-infected 
mothers in Abidjan, Côte d’Ivoire.  
The UNAIDS Guidelines
The authors chose to examine this issue 
because of the continued challenges 
faced by HIV-infected mothers 
regarding infant feeding. Breast-
milk transmission of HIV contributes 
substantially to the risk of infant HIV 
infection; consequently HIV-infected 
mothers in Europe and the United 
States are counseled not to breast-feed 
their infants. However, avoiding breast-
feeding or shortening the term of 
breast-feeding may be risky for infants 
in settings with inadequate sanitation, 
limited access to breast-milk substitutes, 
or unsafe water. Thus, UNAIDS (the 
Joint United Nations Programme on 
HIV/AIDS) recommends that HIV-
infected women “replacement feed” 
their infants when it is acceptable, 
feasible, affordable, sustainable, and 
safe (“replacement feeding” is a term 
used to refer to feeding infants with 
milk other than breast milk, such as 
formula) [2]. 
Interpreting these guidelines is 
particularly challenging on the ground. 
When is replacement feeding safe for 
babies? This issue of safety is the focus 
of Becquet et al’s study—by measuring 
severe morbidity and mortality, 
the authors determined how risky 
replacement feeding and shortened 
breast-feeding were for infants born 
to HIV-infected mothers in an urban 
African setting. 
The New Study
The authors compared morbidity, 
hospitalization, and mortality over a 
two-year period among infants of HIV-
infected women who had received 
peripartum antiretrovirals and elected 
to either breast-feed for four months or 
formula feed. In addition, the authors 
compared the infants in this cohort 
to infants in a historical cohort in the 
same setting with the same clinical and 
survival assessments who breast-fed for 
a prolonged duration. 
Becquet et al. found that at baseline, 
formula-feeding mothers were more 
educated and had better access to tap 
water and less shared housing than 
women who elected to breast-feed for a 
short duration. However, there was no 
evidence that formula-feeding mothers 
in this cohort had more advanced 
HIV disease than women who breast-
fed. Overall, adverse events among 
HIV-uninfected infants were similar in 
the two groups. Formula-fed infants 
had signiﬁ  cantly increased risk of 
diarrhea and acute respiratory illnesses, 
while short-term breast-fed infants 
tended to have a higher incidence of 
malnutrition. However, over two-year 
follow-up, the risk of hospitalization 
or mortality did not differ between the 
two feeding groups. 
In addition, when both groups of 
infants were compared to a historical 
cohort in which breast-feeding 
was prolonged, the authors found 
excellent two-year survival among 
HIV-uninfected children regardless 
of whether they breast-fed long-term 
(95%) or breast-fed for four months or 
never breast-fed (96%).  The authors 
conclude that “given appropriate 
nutritional counseling and care, access 
to clean water, and a supply of breast-
milk substitutes, these alternatives to 
prolonged breast-feeding can be safe 
interventions to prevent mother-to-
child transmission of HIV in urban 
African settings.”
Implications of the Study
These conclusions may be slightly 
provocative in 2007—replacement 
feeding has been abandoned in many 
African settings as a viable intervention 
for prevention of breast-milk HIV 
transmission. The authors provide good 
data to suggest that with appropriate 
provisos, replacement feeding can 
be a safe option to consider for HIV-
infected mothers in urban African 
settings.  
Are these conclusions valid? Yes. 
The study has several strengths—the 
authors have conducted meticulous 
and robust analyses with large cohorts 
including a long period of follow-up. 
The authors had adequate retention 
and detailed morbidity assessment, and 
they included independent assessment 
of morbidity. The authors made use 
of a closely linked historical cohort in 
order to compare prolonged breast-
feeding with shortened or no breast-
feeding. While exclusive breast-feeding 
was not practiced by the majority 
When Is Replacement Feeding Safe 
for Infants of HIV-Infected Women?
Grace C. John-Stewart
Funding: The author received no speciﬁ  c funding for 
this article. 
Competing Interests: The author has declared that 
no competing interests exist.
Citation: GC John-Stewart (2007) When is 
replacement feeding safe for infants of HIV-infected 
women? PLoS Med 4(1): e30. doi:10.1371/journal.
pmed.0040030
Copyright: © 2007 Grace C. John-Stewart. This is 
an open-access article distributed under the terms 
of the Creative Commons Attribution License, 
which permits unrestricted use, distribution, and 
reproduction in any medium, provided the original 
author and source are credited. 
Abbreviations: HAART, highly active antiretroviral 
therapy; PMTCT, prevention of mother-to-child 
transmission of HIV
Grace C. John-Stewart is with the University of 
Washington, Seattle, Washington, United States of 
America. E-mail: gjohn@u.washington.edu
Breast-milk 
transmission of HIV 
contributes substantially 
to the risk of infant HIV 
infection.
The Perspectives section is for experts to discuss the 
clinical practice or public health implications of a 
published article that is freely available online.PLoS Medicine  |  www.plosmedicine.org 0012
of women in the cohort despite 
counseling to do so, the proportion of 
predominantly breast-feeding women 
was similar to other African cohorts 
promoting exclusive breast-feeding and 
probably reﬂ  ects the reality of breast-
feeding practices in similar settings 
[3]. All in all, for a woman in Abidjan, 
the likelihood of having a baby neither 
acquire HIV nor die would be highest 
with peripartum antiretrovirals and no 
or limited breast-feeding. 
Are the conclusions generalizable? 
Perhaps not widely. The ﬁ  ndings of 
this study are consistent with a clinical 
trial in Nairobi, in which infants of 
HIV-infected women randomized 
to formula feed had signiﬁ  cantly 
higher likelihood of not having an 
adverse outcome (either death or 
HIV infection) than the infants of 
women randomized to breast-feed [4]. 
Unfortunately, both studies may be 
hard to generalize to diverse settings in 
Africa. Supplying breast-milk substitutes 
is possible, but ensuring clean water is 
more problematic. In addition, the very 
strengths of the study (i.e., systematic 
frequent follow-up to ascertain 
morbidity and mortality) provided a 
safety net to prevent morbidity and 
mortality due to not breast-feeding 
that may be hard to replicate in a 
busy maternal–child health clinic in 
other settings. Thus, some prevention 
of mother-to-child transmission of 
HIV (PMTCT) programs that have 
provided replacement feeding have 
noted increased hospitalizations among 
infants who were replacement fed [5]. 
In addition, policy makers remain 
concerned about the potential impact 
of replacement feeding spillover from 
PMTCT programs to the general 
community, which could undermine 
efforts to promote breast-feeding [6]. 
Overall, translating safety for infant 
replacement feeding from closely 
observed research cohorts to programs 
can be problematic.
The minimal mortality observed 
by Becquet and colleagues, however, 
may motivate PMTCT programs to 
think more carefully about optimizing 
child health in general. The high two-
year survival in this cohort is laudable 
and reﬂ  ects an important goal for 
PMTCT programs that may currently 
neglect child survival strategies in 
a narrow focus on HIV prevention. 
Incorporating frequent follow-up, 
growth assessment, and morbidity 
assessment and treatment within 
PMTCT follow-up clinics is essential 
to preserve child health beneﬁ  ts in 
addition to preventing infant HIV 
infection. While water safety and 
conﬁ  dentiality issues may still pose 
challenges, strengthened infrastructure 
for infant/child surveillance may 
contribute to making replacement or 
shortened breast-feeding more safe. 
Conclusion
Current research in prevention of 
breast-milk HIV transmission includes 
evaluation of a variety of approaches, 
including optimizing exclusive breast-
feeding, providing antiretrovirals 
during shortened breast-feeding to 
mother or infant, and, ultimately, 
vaccination. Preserving breast-feeding 
is attractive because of nutritional, 
growth, safety, and conﬁ  dentiality 
issues, and in the future these 
approaches may enable prolonged 
breast-feeding.  However, some of the 
interventions currently under study 
may not be as promising as initially 
envisioned. For example, highly active 
antiretroviral therapy (HAART) 
during shortened breast-feeding is 
not the panacea hoped for—it may be 
associated with loss of conﬁ  dentiality, 
toxicity, resistance, and infant 
morbidity and growth compromise 
when breast-feeding is stopped at six 
months. It is plausible that strategizing 
for not breast-feeding from birth 
would be less problematic than ﬁ  rst 
starting to breast-feed on HAART, and 
then stopping after six months. Thus, 
replacement feeding should still be 
considered in the mix of strategies to 
prevent breast-milk transmission of 
HIV, particularly when water safety is 
assured and provision of breast-milk 
substitutes is an option. Becquet et 
al’s data are reassuring that when 
appropriate support is provided and 
clean water is available, replacement 
feeding can be safe in an urban African 
setting.  
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